CYTK CYTOKINETICS INC
Nasdaq · SEC CIK 1061983 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $52.26M 81 sales by 10 insiders
- Filings on record
- 559 since 2021-07-02, latest 2026-09-22 18:14
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| Lee Sung | EVP, CFO | — | $5.70M |
| Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| Kaye Edward M. MD | Dir | — | $3.21M |
| HENDERSON JOHN T | Dir | — | $2.08M |
| WIERENGA WENDELL | Dir | — | $1.88M |
| PARSHALL B LYNNE | Dir | — | $1.36M |
| Landry Robert E | Dir | — | $146.8K |
| Harrington Robert Arthur | Dir | — | $143.6K |
Transactions 784
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-16 | 2023-05-16 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +12.5K | 453.6K | +3% | +$120.6K |
| D | 2023-05-15 | 2023-05-15 | CYTK | HENDERSON JOHN T | Dir | S - Sale+OE | $37.77 | -4,166 | 25.4K | -14% | -$157.3K |
| D | 2023-05-15 | 2023-05-15 | CYTK | HENDERSON JOHN T | Dir | M - OptEx | $6.78 | +4,166 | 29.6K | +16% | +$28.2K |
| 2023-05-11 | 2023-05-11 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $39.50 | -1,787 | 165.4K | -1% | -$70.6K | |
| D | 2023-05-03 | 2023-05-03 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +7,000 | 174.2K | +4% | +$55.7K |
| D | 2023-05-03 | 2023-05-03 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $40.00 | -7,000 | 167.2K | -4% | -$280.0K |
| D | 2023-04-28 | 2023-04-28 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +12.5K | 453.6K | +3% | +$120.6K |
| D | 2023-04-28 | 2023-04-28 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $37.68 | -12.5K | 441.1K | -3% | -$471.0K |
| D | 2023-04-14 | 2023-04-14 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $35.61 | -12.5K | 441.1K | -3% | -$445.1K |
| D | 2023-04-14 | 2023-04-14 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +12.5K | 453.6K | +3% | +$120.6K |
| 2023-04-13 | 2023-04-13 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $34.21 | -4,000 | 167.2K | -2% | -$136.8K | |
| 2023-04-05 | 2023-04-03 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $37.71 | +530 | 25.4K | +2% | +$20.0K | |
| 2023-04-05 | 2023-04-03 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $37.71 | +298 | 12.8K | +2% | +$11.2K | |
| 2023-04-05 | 2023-04-03 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $37.71 | +298 | 12.8K | +2% | +$11.2K | |
| 2023-04-05 | 2023-04-03 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $37.71 | +298 | 5,551 | +6% | +$11.2K | |
| 2023-04-05 | 2023-04-03 | CYTK | Wysenski Nancy | Dir | A - Grant | $37.71 | +149 | 11.7K | +1% | +$5,619 | |
| 2023-04-05 | 2023-04-03 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $37.71 | +298 | 13.3K | +2% | +$11.2K | |
| D | 2023-03-28 | 2023-03-28 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $35.05 | -12.5K | 441.1K | -3% | -$438.1K |
| D | 2023-03-28 | 2023-03-28 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +12.5K | 453.6K | +3% | +$120.6K |
| D | 2023-03-17 | 2023-03-15 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +12.5K | 453.6K | +3% | +$120.6K |
| D | 2023-03-17 | 2023-03-15 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $37.26 | -12.5K | 441.1K | -3% | -$465.8K |
| 2023-03-09 | 2023-03-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $39.10 | -4,000 | 171.2K | -2% | -$156.4K | |
| D | 2023-03-07 | 2023-03-06 | CYTK | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +40.0K | 175.2K | +30% | $0 |
| D | 2023-03-07 | 2023-03-06 | CYTK | Wong Robert | VP, CAO | A - Grant | $0.00 | +6,000 | 27.6K | +28% | $0 |
| 2023-03-07 | 2023-03-06 | CYTK | Wong Robert | VP, CAO | F - Tax | $39.13 | -692 | 21.6K | -3% | -$27.1K | |
| D | 2023-03-07 | 2023-03-06 | CYTK | Blum Robert I | Pres, CEO, Dir | A - Grant | $0.00 | +82.5K | 441.1K | +23% | $0 |
| D | 2023-03-07 | 2023-03-06 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +30.0K | 53.7K | +127% | $0 |
| D | 2023-03-07 | 2023-03-06 | CYTK | Jaw Ching | CFO, SVP Fin | A - Grant | $0.00 | +30.0K | 87.3K | +52% | $0 |
| 2023-03-07 | 2023-03-06 | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $39.13 | -4,958 | 135.2K | -4% | -$194.0K | |
| D | 2023-03-07 | 2023-03-06 | CYTK | Blum Robert I | Pres, CEO, Dir | F - Tax | $39.13 | -11.9K | 358.6K | -3% | -$465.6K |
| D | 2023-03-07 | 2023-03-06 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $39.94 | -12.5K | 370.5K | -3% | -$499.2K |
| D | 2023-03-07 | 2023-03-06 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +12.5K | 383.0K | +3% | +$120.6K |
| 2023-03-07 | 2023-03-06 | CYTK | Jaw Ching | CFO, SVP Fin | F - Tax | $39.13 | -2,403 | 57.3K | -4% | -$94.0K | |
| 2023-03-03 | 2023-03-02 | CYTK | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $39.60 | -2,202 | 23.7K | -9% | -$87.2K | |
| 2023-03-03 | 2023-03-02 | CYTK | Wong Robert | VP, CAO | F - Tax | $39.60 | -2,484 | 22.3K | -10% | -$98.4K | |
| 2023-03-03 | 2023-03-02 | CYTK | Jaw Ching | CFO, SVP Fin | F - Tax | $39.60 | -6,225 | 59.7K | -9% | -$246.5K | |
| 2023-03-03 | 2023-03-02 | CYTK | Blum Robert I | Pres, CEO, Dir | F - Tax | $39.60 | -32.7K | 370.5K | -8% | -$1.30M | |
| 2023-03-03 | 2023-03-02 | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $39.60 | -10.8K | 140.1K | -7% | -$427.1K | |
| 2023-02-21 | 2023-02-21 | CYTK | Wong Robert | VP, CAO | S - Sale | $45.21 | -2,234 | 24.8K | -8% | -$101.0K | |
| 2023-02-17 | 2023-02-16 | CYTK | Wong Robert | VP, CAO | F - Tax | $44.13 | -510 | 27.0K | -2% | -$22.5K | |
| 2023-02-17 | 2023-02-16 | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $44.13 | -1,513 | 150.9K | -1.0% | -$66.8K | |
| 2023-02-17 | 2023-02-16 | CYTK | Blum Robert I | Pres, CEO, Dir | F - Tax | $44.13 | -3,230 | 403.2K | -0.8% | -$142.5K | |
| 2023-02-17 | 2023-02-16 | CYTK | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $44.13 | -969 | 25.9K | -4% | -$42.8K | |
| 2023-02-17 | 2023-02-16 | CYTK | Jaw Ching | CFO, SVP Fin | F - Tax | $44.13 | -1,210 | 66.0K | -2% | -$53.4K | |
| 2023-02-10 | 2023-02-10 | CYTK | Malik Fady Ibraham | EVP Research, Development | G - Gift | $0.00 | -150 | 152.4K | -0.1% | $0 | |
| 2023-02-09 | 2023-02-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $43.73 | -4,000 | 152.6K | -3% | -$174.9K | |
| D | 2023-02-09 | 2023-02-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +7,000 | 163.6K | +4% | +$55.7K |
| D | 2023-02-09 | 2023-02-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $43.74 | -7,000 | 156.6K | -4% | -$306.2K |
| D | 2023-02-08 | 2023-02-06 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $6.72 | +7,000 | 19.5K | +56% | +$47.0K |
| D | 2023-02-08 | 2023-02-06 | CYTK | WIERENGA WENDALL | Dir | S - Sale+OE | $45.00 | -7,000 | 12.5K | -36% | -$315.0K |
| D | 2023-02-07 | 2023-02-03 | CYTK | Jaw Ching | CFO, SVP Fin | M - OptEx | $12.10 | +15.0K | 82.2K | +22% | +$181.5K |
| D | 2023-02-07 | 2023-02-03 | CYTK | Jaw Ching | CFO, SVP Fin | S - Sale+OE | $45.00 | -15.0K | 67.2K | -18% | -$675.0K |
| 2023-02-06 | 2023-02-03 | CYTK | Wong Robert | VP, CAO | S - Sale | $45.00 | -3,004 | 27.5K | -10% | -$135.2K | |
| D | 2023-01-19 | 2023-01-17 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +10.0K | 416.4K | +2% | +$96.5K |
| D | 2023-01-19 | 2023-01-17 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $42.43 | -10.0K | 406.4K | -2% | -$424.3K |
| 2023-01-12 | 2023-01-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $40.47 | -4,000 | 156.6K | -2% | -$161.9K | |
| D | 2023-01-06 | 2023-01-04 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +10.0K | 416.4K | +2% | +$96.5K |
| D | 2023-01-06 | 2023-01-04 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $44.24 | -10.0K | 406.4K | -2% | -$442.4K |
| 2023-01-04 | 2023-01-03 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $44.35 | +253 | 12.5K | +2% | +$11.2K | |
| 2023-01-04 | 2023-01-03 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $44.35 | +450 | 24.9K | +2% | +$20.0K | |
| 2023-01-04 | 2023-01-03 | CYTK | Wysenski Nancy | Dir | A - Grant | $44.35 | +126 | 11.5K | +1% | +$5,588 | |
| 2023-01-04 | 2023-01-03 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $44.35 | +253 | 13.0K | +2% | +$11.2K | |
| 2023-01-04 | 2023-01-03 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $44.35 | +253 | 5,253 | +5% | +$11.2K | |
| 2023-01-04 | 2023-01-03 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $44.35 | +253 | 12.5K | +2% | +$11.2K | |
| 2022-12-08 | 2022-12-08 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $36.28 | -4,000 | 160.6K | -2% | -$145.1K | |
| D | 2022-12-05 | 2022-12-05 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +10.0K | 416.4K | +2% | +$96.5K |
| D | 2022-12-05 | 2022-12-05 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $39.30 | -10.0K | 406.4K | -2% | -$393.0K |
| D | 2022-11-23 | 2022-11-21 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +10.0K | 416.1K | +2% | +$96.5K |
| D | 2022-11-23 | 2022-11-21 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $40.89 | -10.0K | 406.1K | -2% | -$408.9K |
| 2022-11-15 | 2022-11-14 | CYTK | Wong Robert | VP, CAO | S - Sale | $40.68 | -2,100 | 30.5K | -6% | -$85.4K | |
| 2022-11-10 | 2022-11-10 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $38.04 | -4,000 | 164.3K | -2% | -$152.2K | |
| DM | 2022-11-04 | 2022-11-02 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $8.09 | +10.0K | 406.9K | +3% | +$80.9K |
| DM | 2022-11-04 | 2022-11-02 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $42.17 | -10.0K | 406.1K | -2% | -$421.7K |
| D | 2022-10-21 | 2022-10-19 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $47.86 | -10.0K | 406.1K | -2% | -$478.6K |
| D | 2022-10-21 | 2022-10-19 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 416.1K | +2% | +$79.6K |
| D | 2022-10-13 | 2022-10-13 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $9.65 | +21.5K | 189.9K | +13% | +$207.6K |
| D | 2022-10-13 | 2022-10-13 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $47.28 | -21.5K | 168.3K | -11% | -$1.02M |
| 2022-10-05 | 2022-10-03 | CYTK | Bhanji Muna | Dir | A - Grant | $51.11 | +220 | 11.0K | +2% | +$11.2K | |
| 2022-10-05 | 2022-10-03 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $51.11 | +110 | 12.3K | +0.9% | +$5,622 | |
| 2022-10-05 | 2022-10-03 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $51.11 | +220 | 12.8K | +2% | +$11.2K | |
| 2022-10-05 | 2022-10-03 | CYTK | Wysenski Nancy | Dir | A - Grant | $51.11 | +110 | 11.4K | +1.0% | +$5,622 | |
| D | 2022-10-05 | 2022-10-03 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 416.1K | +2% | +$79.6K |
| D | 2022-10-05 | 2022-10-03 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $50.40 | -10.0K | 406.1K | -2% | -$504.0K |
| 2022-10-05 | 2022-10-03 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $51.11 | +391 | 24.4K | +2% | +$20.0K | |
| 2022-10-05 | 2022-10-03 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $51.11 | +110 | 12.3K | +0.9% | +$5,622 | |
| D | 2022-09-21 | 2022-09-19 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $51.42 | -10.0K | 406.1K | -2% | -$514.2K |
| D | 2022-09-21 | 2022-09-19 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 416.1K | +2% | +$79.6K |
| DM | 2022-09-12 | 2022-09-12 | CYTK | HENDERSON JOHN T | Dir | S - Sale+OE | $54.94 | -21.8K | 24.0K | -48% | -$1.20M |
| DM | 2022-09-12 | 2022-09-12 | CYTK | HENDERSON JOHN T | Dir | M - OptEx | $4.02 | +21.8K | 31.3K | +228% | +$87.5K |
| D | 2022-09-09 | 2022-09-08 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $51.88 | -21.5K | 168.3K | -11% | -$1.12M |
| D | 2022-09-09 | 2022-09-08 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $9.65 | +21.5K | 189.8K | +13% | +$207.5K |
| D | 2022-09-09 | 2022-09-07 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 416.1K | +2% | +$79.6K |
| D | 2022-09-09 | 2022-09-07 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $49.11 | -10.0K | 406.1K | -2% | -$491.1K |
| D | 2022-09-02 | 2022-09-02 | CYTK | SMITH SANDFORD D | Dir | S - Sale+OE | $53.97 | -11.4K | 12.2K | -48% | -$613.6K |
| DM | 2022-09-02 | 2022-09-02 | CYTK | SMITH SANDFORD D | Dir | M - OptEx | $23.66 | +11.4K | 15.2K | +296% | +$269.0K |
| DM | 2022-09-01 | 2022-09-01 | CYTK | Dir | M - OptEx | $10.27 | +15.0K | 15.0K | New | +$154.1K | |
| D | 2022-09-01 | 2022-09-01 | CYTK | Dir | S - Sale+OE | $52.79 | -15.0K | 10.0K | -60% | -$791.9K | |
| D | 2022-09-01 | 2022-09-01 | CYTK | WIERENGA WENDALL | Dir | S - Sale+OE | $52.79 | -4,166 | 12.2K | -26% | -$219.9K |
| D | 2022-09-01 | 2022-09-01 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $6.78 | +4,166 | 16.3K | +34% | +$28.2K |
| D | 2022-09-01 | 2022-09-01 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $52.79 | -30.3K | 10.0K | -75% | -$1.60M |
Purchase Sale Sale after option exercise All abbreviations